Medicare Rx Funding Will Exceed $400 Bil., Breaux Predicts; War No Obstacle
Executive Summary
Senate Medicare Rx legislation is likely to exceed the $400 bil. in funding set aside for the program by President Bush, Sen. John Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting March 28 in Naples, Fla
You may also be interested in...
Medicaid Reform Should Be PhRMA Priority, HHS Secretary Thompson Says
Passage of a Medicaid reform bill would do more to improve the pharmaceutical industry's image than a Medicare prescription drug benefit, HHS Secretary Thompson maintained during the PhRMA annual meeting in Naples, Fla. March 29
Rx Industry Must Take Phase IV “Seriously,” Commissioner Tells PhRMA
Pharmaceutical manufacturers need to step up their commitment to postmarketing surveillance and studies, FDA Commissioner McClellan told the Pharmaceutical Research & Manufacturers of America March 28 in Naples, Fla
White House Medicare Rx Draft Proposes “Enhanced” Fee For Service Option
The Bush Administration is considering an "enhanced" fee-for-service Medicare program that would offer a prescription drug benefit for seniors beginning in 2006